In the study reported here, we found that systemic buffering by oral NaHCO3 paradoxically negated the effect of anti-PD1, an immune checkpoint inhibitor, in an inducible MYC–driven mouse hepatocellular carcinoma (HCC) model (18). Here, PDCD1 is linked to hepatocellular carcinoma.